Compound ID | 3300
FNDR-20364
Synonym(s): FNDR20364 | FNDR 20364
Class: Antimicrobial peptide
| Agent Type: | Natural product; Direct acting; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Protein synthesis inhibitor. Inhibits ribosome associated GTPase activity |
| Target Pathogen: | Active against Mycobacterium tuberculosis |
| Description: | Natural product; developed as inhalation drug |
| Institute where first reported: | Working Group for New TB Drugs and National Centre of Oceanic and Antarctic Research (NCAOR) Goa |
| Year first mentioned: | 2021 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citation: | https://pmc.ncbi.nlm.nih.gov/articles/PMC9582839/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.